27.91 USD
+1.1 (+4.1%)
27.91 USD
0 (0%)
We assign a fundamental rating of 6 out of 10 to TCMD. TCMD was compared to 187 industry peers in the Health Care Equipment & Supplies industry. TCMD has an excellent financial health rating, but there are some minor concerns on its profitability. TCMD is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make TCMD suitable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year TCMD was profitable.
In the past year TCMD had a positive cash flow from operations.
In multiple years TCMD reported negative net income over the last 5 years.
Each year in the past 5 years TCMD had a positive operating cash flow.
1.2 Ratios
TCMD has a Return On Assets of 7.01%. This is amongst the best in the industry. TCMD outperforms 87.70% of its industry peers.
Looking at the Return On Equity, with a value of 8.86%, TCMD belongs to the top of the industry, outperforming 83.42% of the companies in the same industry.
The Return On Invested Capital of TCMD (7.56%) is better than 82.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.01% | ||
| ROE | 8.86% | ||
| ROIC | 7.56% |
ROA(3y)2.94%
ROA(5y)0.73%
ROE(3y)2.6%
ROE(5y)-0.37%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 5.83%, TCMD is in the better half of the industry, outperforming 78.07% of the companies in the same industry.
TCMD's Profit Margin has been stable in the last couple of years.
Looking at the Operating Margin, with a value of 7.39%, TCMD is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
In the last couple of years the Operating Margin of TCMD has grown nicely.
The Gross Margin of TCMD (49.88%) is comparable to the rest of the industry.
TCMD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.39% | ||
| PM (TTM) | 5.83% | ||
| GM | 49.88% |
OM growth 3YN/A
OM growth 5Y6.44%
PM growth 3YN/A
PM growth 5Y-0.06%
GM growth 3Y3.35%
GM growth 5Y-0.43%
2. Health
2.1 Basic Checks
TCMD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
TCMD has more shares outstanding than it did 1 year ago.
The number of shares outstanding for TCMD has been increased compared to 5 years ago.
Compared to 1 year ago, TCMD has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 9.11 indicates that TCMD is not in any danger for bankruptcy at the moment.
TCMD has a better Altman-Z score (9.11) than 88.77% of its industry peers.
TCMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 9.11 |
ROIC/WACC0.87
WACC8.64%
2.3 Liquidity
A Current Ratio of 3.61 indicates that TCMD has no problem at all paying its short term obligations.
The Current ratio of TCMD (3.61) is better than 62.57% of its industry peers.
TCMD has a Quick Ratio of 3.20. This indicates that TCMD is financially healthy and has no problem in meeting its short term obligations.
TCMD's Quick ratio of 3.20 is fine compared to the rest of the industry. TCMD outperforms 66.84% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.61 | ||
| Quick Ratio | 3.2 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 16.67% over the past year.
Measured over the past 5 years, TCMD shows a small growth in Earnings Per Share. The EPS has been growing by 4.86% on average per year.
Looking at the last year, TCMD shows a quite strong growth in Revenue. The Revenue has grown by 9.28% in the last year.
TCMD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.11% yearly.
EPS 1Y (TTM)16.67%
EPS 3YN/A
EPS 5Y4.86%
EPS Q2Q%71.43%
Revenue 1Y (TTM)9.28%
Revenue growth 3Y12.08%
Revenue growth 5Y9.11%
Sales Q2Q%17.32%
3.2 Future
The Earnings Per Share is expected to grow by 20.90% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 8.94% on average over the next years. This is quite good.
EPS Next Y14.64%
EPS Next 2Y16.58%
EPS Next 3Y20.9%
EPS Next 5YN/A
Revenue Next Year9.19%
Revenue Next 2Y9.01%
Revenue Next 3Y8.94%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
TCMD is valuated quite expensively with a Price/Earnings ratio of 36.25.
71.12% of the companies in the same industry are more expensive than TCMD, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.49. TCMD is valued slightly more expensive when compared to this.
The Price/Forward Earnings ratio is 28.92, which means the current valuation is very expensive for TCMD.
Based on the Price/Forward Earnings ratio, TCMD is valued a bit cheaper than the industry average as 73.26% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of TCMD to the average of the S&P500 Index (23.69), we can say TCMD is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.25 | ||
| Fwd PE | 28.92 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, TCMD is valued a bit cheaper than the industry average as 79.68% of the companies are valued more expensively.
93.58% of the companies in the same industry are more expensive than TCMD, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.83 | ||
| EV/EBITDA | 17.74 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of TCMD may justify a higher PE ratio.
A more expensive valuation may be justified as TCMD's earnings are expected to grow with 20.90% in the coming years.
PEG (NY)2.48
PEG (5Y)7.46
EPS Next 2Y16.58%
EPS Next 3Y20.9%
5. Dividend
5.1 Amount
No dividends for TCMD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
27.91
+1.1 (+4.1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners98.46%
Inst Owner Change-2.68%
Ins Owners2.66%
Ins Owner Change-0.47%
Market Cap623.51M
Revenue(TTM)311.51M
Net Income(TTM)18.17M
Analysts81.82
Price Target24.48 (-12.29%)
Short Float %7.74%
Short Ratio4.22
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)64.96%
Min EPS beat(2)27.09%
Max EPS beat(2)102.84%
EPS beat(4)3
Avg EPS beat(4)18.21%
Min EPS beat(4)-82.07%
Max EPS beat(4)102.84%
EPS beat(8)7
Avg EPS beat(8)30.85%
EPS beat(12)11
Avg EPS beat(12)304.86%
EPS beat(16)11
Avg EPS beat(16)169.54%
Revenue beat(2)2
Avg Revenue beat(2)5.32%
Min Revenue beat(2)4.63%
Max Revenue beat(2)6.01%
Revenue beat(4)2
Avg Revenue beat(4)0.95%
Min Revenue beat(4)-5.08%
Max Revenue beat(4)6.01%
Revenue beat(8)3
Avg Revenue beat(8)-0.62%
Revenue beat(12)6
Avg Revenue beat(12)0.51%
Revenue beat(16)10
Avg Revenue beat(16)1.53%
PT rev (1m)42.57%
PT rev (3m)77.78%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)29.13%
EPS NY rev (3m)26.27%
Revenue NQ rev (1m)0.41%
Revenue NQ rev (3m)0.99%
Revenue NY rev (1m)2.44%
Revenue NY rev (3m)2.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.25 | ||
| Fwd PE | 28.92 | ||
| P/S | 2 | ||
| P/FCF | 15.83 | ||
| P/OCF | 14.9 | ||
| P/B | 3.04 | ||
| P/tB | 4.66 | ||
| EV/EBITDA | 17.74 |
EPS(TTM)0.77
EY2.76%
EPS(NY)0.96
Fwd EY3.46%
FCF(TTM)1.76
FCFY6.32%
OCF(TTM)1.87
OCFY6.71%
SpS13.94
BVpS9.17
TBVpS5.99
PEG (NY)2.48
PEG (5Y)7.46
Graham Number12.61
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.01% | ||
| ROE | 8.86% | ||
| ROCE | 10.46% | ||
| ROIC | 7.56% | ||
| ROICexc | 11.94% | ||
| ROICexgc | 24.41% | ||
| OM | 7.39% | ||
| PM (TTM) | 5.83% | ||
| GM | 49.88% | ||
| FCFM | 12.65% |
ROA(3y)2.94%
ROA(5y)0.73%
ROE(3y)2.6%
ROE(5y)-0.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y15.26%
ROICexc growth 3YN/A
ROICexc growth 5Y1.86%
OM growth 3YN/A
OM growth 5Y6.44%
PM growth 3YN/A
PM growth 5Y-0.06%
GM growth 3Y3.35%
GM growth 5Y-0.43%
F-Score7
Asset Turnover1.2
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 36.37% | ||
| Cap/Sales | 0.79% | ||
| Interest Coverage | 17.31 | ||
| Cash Conversion | 140.64% | ||
| Profit Quality | 216.85% | ||
| Current Ratio | 3.61 | ||
| Quick Ratio | 3.2 | ||
| Altman-Z | 9.11 |
F-Score7
WACC8.64%
ROIC/WACC0.87
Cap/Depr(3y)35.17%
Cap/Depr(5y)50.34%
Cap/Sales(3y)0.85%
Cap/Sales(5y)0.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.67%
EPS 3YN/A
EPS 5Y4.86%
EPS Q2Q%71.43%
EPS Next Y14.64%
EPS Next 2Y16.58%
EPS Next 3Y20.9%
EPS Next 5YN/A
Revenue 1Y (TTM)9.28%
Revenue growth 3Y12.08%
Revenue growth 5Y9.11%
Sales Q2Q%17.32%
Revenue Next Year9.19%
Revenue Next 2Y9.01%
Revenue Next 3Y8.94%
Revenue Next 5YN/A
EBIT growth 1Y7.23%
EBIT growth 3YN/A
EBIT growth 5Y16.13%
EBIT Next Year85.47%
EBIT Next 3Y35.54%
EBIT Next 5YN/A
FCF growth 1Y99.58%
FCF growth 3Y420.83%
FCF growth 5YN/A
OCF growth 1Y95.92%
OCF growth 3Y149.11%
OCF growth 5Y74.54%
TACTILE SYSTEMS TECHNOLOGY I / TCMD FAQ
Can you provide the ChartMill fundamental rating for TACTILE SYSTEMS TECHNOLOGY I?
ChartMill assigns a fundamental rating of 6 / 10 to TCMD.
What is the valuation status for TCMD stock?
ChartMill assigns a valuation rating of 4 / 10 to TACTILE SYSTEMS TECHNOLOGY I (TCMD). This can be considered as Fairly Valued.
What is the profitability of TCMD stock?
TACTILE SYSTEMS TECHNOLOGY I (TCMD) has a profitability rating of 6 / 10.
What are the PE and PB ratios of TACTILE SYSTEMS TECHNOLOGY I (TCMD) stock?
The Price/Earnings (PE) ratio for TACTILE SYSTEMS TECHNOLOGY I (TCMD) is 36.25 and the Price/Book (PB) ratio is 3.04.
Can you provide the financial health for TCMD stock?
The financial health rating of TACTILE SYSTEMS TECHNOLOGY I (TCMD) is 8 / 10.